Treatment and health outcomes in adults with congenital adrenal hyperplasia (Q34392232)

1 August 2017

Treatment and health outcomes in adults with congenital adrenal hyperplasia (English)

1 reference

1 August 2017

0 references

Thang S Han

1

0 references

Wiebke Arlt

object named as

Wiebke Arlt

series ordinal

3

0 references

author name string

Brian R Walker

series ordinal

2

1 reference

PubMed ID

24342885

1 August 2017

Richard J Ross

series ordinal

4

1 reference

1 August 2017

17 December 2013

1 reference

Nature Reviews Endocrinology

1 August 2017

1 reference

1 August 2017

10

1 reference

1 August 2017

115-124

1 reference

1 August 2017

2

1 reference

https://scigraph.springernature.com/pub.10.1038/nrendo.2013.239

1 August 2017

0 references

cites work

Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.239

The molecular biology, biochemistry, and physiology of human steroidogenesis and its disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.239

Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an Endocrine Society clinical practice guideline

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.239

Congenital adrenal hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.239

Consensus statement on 21-hydroxylase deficiency from the European Society for Paediatric Endocrinology and the Lawson Wilkins Pediatric Endocrine Society

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.239

Health status of adults with congenital adrenal hyperplasia: a cohort study of 203 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.239

Health problems in congenital adrenal hyperplasia due to 21-hydroxylase deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.239

Clinical outcomes in the management of congenital adrenal hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.239

One hundred years of congenital adrenal hyperplasia in Sweden: a retrospective, population-based cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.239

Comprehensive genetic analysis of 182 unrelated families with congenital adrenal hyperplasia due to 21-hydroxylase deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.239

Congenital adrenal hyperplasia and P450 oxidoreductase deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.239

Results of screening 1.9 million Texas newborns for 21-hydroxylase-deficient congenital adrenal hyperplasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.239

Approach to the patient: the adult with congenital adrenal hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.239

Disease expression and molecular genotype in congenital adrenal hyperplasia due to 21-hydroxylase deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.239

Genetics of congenital adrenal hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.239

Congenital adrenal hyperplasia due to 21-hydroxylase deficiency: A paradigm for prenatal diagnosis and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.239

Genotype-phenotype correlation in 1,507 families with congenital adrenal hyperplasia owing to 21-hydroxylase deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.239

Structure-phenotype correlations of human CYP21A2 mutations in congenital adrenal hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.239

Gender role behavior, sexuality, and psychosocial adaptation in women with congenital adrenal hyperplasia due to CYP21A2 deficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.239

Genotype-phenotype correlation in 153 adult patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency: analysis of the United Kingdom Congenital adrenal Hyperplasia Adult Study Executive (CaHASE) cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.239

A Summary of the Endocrine Society Clinical Practice Guidelines on Congenital Adrenal Hyperplasia due to Steroid 21-Hydroxylase Deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.239

Modified-release hydrocortisone to provide circadian cortisol profiles

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.239

Altered insulin requirement in patients with type 1 diabetes and primary adrenal insufficiency receiving standard glucocorticoid replacement therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.239

Impact of sleep debt on metabolic and endocrine function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.239

Approach to the adult with congenital adrenal hyperplasia due to 21-hydroxylase deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.239

Glucocorticoids and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.239

Clinical characteristics of a cohort of 244 patients with congenital adrenal hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.239

Glucocorticoid treatment regimen and health outcomes in adults with congenital adrenal hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.239

Effects of adrenal steroids on the bone metabolism of children with congenital adrenal hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.239

Control of childhood congenital adrenal hyperplasia and sleep activity and quality with morning or evening glucocorticoid therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.239

Management of altered hydrocortisone pharmacokinetics in a boy with congenital adrenal hyperplasia using a continuous subcutaneous hydrocortisone infusion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.239

A pharmacokinetic and pharmacodynamic study of delayed- and extended-release hydrocortisone (Chronocort) vs. conventional hydrocortisone (Cortef) in the treatment of congenital adrenal hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.239

Blood pressure in children and adolescents with congenital adrenal hyperplasia (21-hydroxylase deficiency): a preliminary report

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.239

Congenital adrenal hyperplasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.239

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.239

Outcome of bilateral adrenalectomy in congenital adrenal hyperplasia: one unit's experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.239

Diagnosis and therapy surveillance in Addison's disease: rapid adrenocorticotropin (ACTH) test and measurement of plasma ACTH, renin activity, and aldosterone

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.239

170H-progesterone rhythms in congenital adrenal hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.239

Comparison of multiple steroid concentrations in serum and dried blood spots throughout the day of patients with congenital adrenal hyperplasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.239

Impaired sexual and reproductive outcomes in women with classical forms of congenital adrenal hyperplasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.239

Fertility in women with nonclassical congenital adrenal hyperplasia due to 21-hydroxylase deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.239

High prevalence of testicular adrenal rest tumors, impaired spermatogenesis, and Leydig cell failure in adolescent and adult males with congenital adrenal hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.239

Testicular adrenal rest tumors and Leydig and Sertoli cell function in boys with classical congenital adrenal hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.239

Testicular adrenal rest tumors develop independently of long-term disease control: a longitudinal analysis of 50 adult men with congenital adrenal hyperplasia due to classic 21-hydroxylase deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.239

Fertility, sexuality and testicular adrenal rest tumors in adult males with congenital adrenal hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.239

An unusual reciprocal X-autosome translocation in an infertile azoospermic man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.239

Classical forms of congenital adrenal hyperplasia due to 21-hydroxylase deficiency in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.239

Genotyping of congenital adrenal hyperplasia due to 21-hydroxylase deficiency presenting as male infertility: case report and literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.239

Ovarian adrenal rest tumor in a congenital adrenal hyperplasia patient with adrenocorticotropin hypersecretion following adrenalectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.239

Use of PET/CT with cosyntropin stimulation to identify and localize adrenal rest tissue following adrenalectomy in a woman with congenital adrenal hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.239

What is the best diagnostic and therapeutic management strategy for an Addison patient during pregnancy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.239

Cognitive functions in children at risk for congenital adrenal hyperplasia treated prenatally with dexamethasone

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.239

Preimplantation genetic diagnosis (PGD)--prevention of the birth of children affected with endocrine diseases.

21 January 2018

2 references

https://api.crossref.org/works/10.1038%2FNRENDO.2013.239

21 January 2018

12 December 2020

Quality of life is less impaired in adults with congenital adrenal hyperplasia because of 21-hydroxylase deficiency than in patients with primary adrenal insufficiency.

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.239

Subjective health status in men and women with congenital adrenal hyperplasia: a population-based survey in Norway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.239

Quality of life in adults with congenital adrenal hyperplasia relates to glucocorticoid treatment, adiposity and insulin resistance: United Kingdom Congenital adrenal Hyperplasia Adult Study Executive (CaHASE).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.239

Gender development in women with congenital adrenal hyperplasia as a function of disorder severity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.239

Metabolic profile and body composition in adult women with congenital adrenal hyperplasia due to 21-hydroxylase deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.239

Cardiovascular risk, metabolic profile, and body composition in adult males with congenital adrenal hyperplasia due to 21-hydroxylase deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.239

Type of Mutation and Surgical Procedure Affect Long-Term Quality of Life for Women with Congenital Adrenal Hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.239

Duplication of the CYP21A2 gene complicates mutation analysis of steroid 21-hydroxylase deficiency: characteristics of three unusual haplotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.239

Adrenomedullary function may predict phenotype and genotype in classic 21-hydroxylase deficiency.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.239

Predicting phenotype in steroid 21-hydroxylase deficiency? Comprehensive genotyping in 155 unrelated, well defined patients from southern Germany

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.239

Circadian hydrocortisone infusions in patients with adrenal insufficiency and congenital adrenal hyperplasia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.239

Modified-release hydrocortisone for circadian therapy: a proof-of-principle study in dexamethasone-suppressed normal volunteers

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.239

An oral multiparticulate, modified-release, hydrocortisone replacement therapy that provides physiological cortisol exposure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.239

Altered 24-hour blood pressure profiles in children and adolescents with classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.239

Reassessing fecundity in women with classical congenital adrenal hyperplasia (CAH): normal pregnancy rate but reduced fertility rate

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.239

Fertility rates in female patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.239

The prevalence of polycystic ovaries in patients with congenital adrenal hyperplasia and their close relatives

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.239

Long-term follow-up of female patients with congenital adrenal hyperplasia from 21-hydroxylase deficiency, with special emphasis on the results of vaginoplasty

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.239

Testicular adrenal rest tumors in patients with congenital adrenal hyperplasia can cause severe testicular damage

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.239

Testicular adrenal rest tissue in congenital adrenal hyperplasia: comparison of MR imaging and sonographic findings

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.239

Ovarian adrenal-like tissue in congenital adrenal hyperplasia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.239

Repeated successful induction of fertility after replacing hydrocortisone with dexamethasone in a patient with congenital adrenal hyperplasia and testicular adrenal rest tumors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.239

Unilateral adrenal tumor, erectile dysfunction and infertility in a patient with 21-hydroxylase deficiency: effects of glucocorticoid treatment and surgery

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.239

Giant bilateral myelolipomas in a man with congenital adrenal hyperplasia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.239

Impaired cognitive function in women with congenital adrenal hyperplasia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.239

Outcome of congenital adrenal hyperplasia.

31 March 2020

1 reference

12 December 2020

Congenital adrenal hyperplasia in the adult patient

1 reference

12 December 2020

Genotyping of CYP21, linked chromosome 6p markers, and a sex-specific gene in neonatal screening for congenital adrenal hyperplasia

1 reference

12 December 2020

Long term outcome in adult males with classic congenital adrenal hyperplasia

1 reference

12 December 2020

Metabolic effects of short-term elevations of plasma cortisol are more pronounced in the evening than in the morning

1 reference

12 December 2020

Plasma levels of aldosterone, corticosterone, 11-deoxycorticosterone, progesterone, 17-hydroxyprogesterone, cortisol, and cortisone during infancy and childhood

1 reference

12 December 2020

Unfavourable trends in cardiovascular and metabolic risk in paediatric and adult patients with congenital adrenal hyperplasia?

1 reference

12 December 2020

Long-term outcome of classical 21-hydroxylase deficiency: diagnosis, complications and quality of life

1 reference

12 December 2020

Congenital adrenal hyperplasia due to 21-hydroxylase deficiency

1 reference

12 December 2020

Worldwide experience in newborn screening for classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency

1 reference

12 December 2020

Mutational spectrum of the steroid 21-hydroxylase gene in Sweden: implications for genetic diagnosis and association with disease manifestation

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRENDO.2013.239

1 reference

1 August 2017

1 reference

PubMed ID

24342885